|
Dacarbazine Clinical Trials
10 actively recruiting trials across 4 locations
Also known as: 4-(Dimethyltriazeno)imidazole-5-carboxamide, 5-(Dimethyltriazeno)imidazole-4-carboxamide, ABVD, Asercit, Biocarbazine +20 more
Pipeline
Phase 2: 4Phase 3: 5Phase 4: 1
Top Sponsors
- University of Miami1
- University College, London1
- Takeda1
- Swiss Cancer Institute1
- State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia1
Indications
- Cancer10
- Hodgkin Lymphoma4
- Hodgkin Lymphoma, Adult2
- Melanoma, Cutaneous Malignant1
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v81
Other4 trials
Phoenix, Arizona2 trials
Miami, Florida2 trials
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
University of Miami
Phase 2
BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma
University of Miami
Phase 2
Birmingham, Alabama1 trial
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Children's Hospital of Alabama
Phase 3
Stanford, California1 trial
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Stanford University - (Stanford Cancer Institute)
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.